Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06293339 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 27, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Nov 1, 2024 to Jul 1, 2025 Start date: Jun 1, 2024 to Mar 1, 2025 · Completion date: May 31, 2025 to Sep 30, 2025 · Eligibility criteria shortened, about 8 wordsv2 Show 3 more changesShow less
    • Start date: Jun 1, 2024 to Mar 1, 2025
    • Completion date: May 31, 2025 to Sep 30, 2025
    • Eligibility criteria shortened, about 8 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will assess the durability of protection of a single immunisation with the Genetically Attenuated Parasite 2 (GA2) against controlled human malaria infection by rechallenging previously immunised and protected participants from the CoGA study (NCT05468606)
Trial Details
NCT Number NCT06293339
Lead Sponsor Leiden University Medical Center
Conditions Malaria,Falciparum
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov